Findings
========

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the presence of extracellular amyloid beta (Aβ) plaques, neurofibrillary tangles, and severe loss of synapses and neurons [@B1]. One of the limitations of AD mouse models has been the absence of cell loss in many of them [@B2][@B3][@B4], although systematic head-to-head comparison of neuronal loss in mouse models has been hindered by the fact that high-quality morphometry is not routinely available or achieved. Furthermore, there are a number of non-stereologic approaches, prone to observer biases, which are often employed but fail to produce comparable results, within a laboratory as well as across studies. As a result, reliable quantification of neuronal loss has not been routinely included in the characterization of mouse models. Absence of data on neuronal loss reduces the usefulness in specifying how particular transgenes and interventions impact neuronal integrity. Here, we examined changes in total cell (i.e., neurons and glia) and total neuronal numbers and densities in two mouse models of AD harboring different APP mutations and exhibiting different panoplies of Aβ biophysical phenotypes: the TgCRND8 mouse and the Dutch APP mouse. TgCRND8 mice express the Swedish (K670M/N671L) and Indiana (V717F) APP mutations, and exhibit increases in total production of Aβ and in the Aβ~42~/Aβ~40~ ratio, leading to accumulation of intraneuronal Aβ, Aβ amyloid plaques, soluble oligomeric Aβ (oAβ), and insoluble fibrillar Aβ (fAβ) [@B5]. The Dutch mouse expresses the E693Q mutation that favors the production of oAβ over fAβ and accumulates intraneuronal Aβ and oAβ [@B3](Additional file [1](#S1){ref-type="supplementary-material"}: Table S1; Figure [1](#F1){ref-type="fig"}).

![**APP/Aβ pathology in the hippocampus of TgCRND8 mutant APP and Dutch mutant APP transgenic mice.** Aβ and APP species were visualized using the 6E10 antibody. Extracellular amyloid plaques (asterisk) are evident in (**B**) TgCRND8 APP transgenic mice (3.5 months old), while (**C**) Dutch mutant APP (17 months old) exhibit intracellular APP/Aβ-like immunoreactivity (APP/Aβ-LIR; arrow). No APP/Aβ-LIR is seen when 6E10 is used to immunostain brain of a wild type mouse (**A**). Inset panels represent higher magnification of 6E10 immunoreactivity of plaques in TgCRND8 mutant APP mice and intracellular APP/Aβ-LIR in Dutch mutant APP mice. Scale bars represent 500 μm. Scale bars in insets represent 100 μm.](1750-1326-7-58-1){#F1}

We employed the isotropic fractionator method [@B6], and quantified cell and neuronal populations in these two different APP mouse lines that we predicted would demonstrate different levels of neuronal integrity. When comparing our total cell numbers to published estimates from wildtype mouse brains, we found that they were comparable to those reported for whole brain using the isotropic fractionator [@B7], and for specific brain regions such as the cerebellum, as estimated by isotropic fractionator and flow cytometry [@B8], and the hippocampus as assessed by traditional stereology [@B9][@B10][@B11][@B12](Table [1](#T1){ref-type="table"}). When assessing total cell and neuron populations, we found no differences in total and regional brain weights between transgenic mice and their respective littermates. We also did not find any differences in total cell counts or densities between TgCRND8 mutant APP mice and controls (Figure [2A](#F2){ref-type="fig"}-F). However, we observed significantly fewer (31.8%) hippocampal neurons between TgCRND8 mutant APP mice and their non-transgenic littermates (*t*~(12)~ = 2.391, p = 0.033; Figure [2H](#F2){ref-type="fig"}). No significant differences were observed in total neuronal counts or densities in neocortex or cerebellum (Figure [2G](#F2){ref-type="fig"}, I-L). When we studied Dutch mutant APP mice, we found no significant differences from controls in total cell count, neuronal cell count, cell density, or neuronal density (Figure [2](#F2){ref-type="fig"}). We did not observe neuronal density changes in the neocortex, perhaps because of region- or even layer-specific vulnerability of select neuronal populations. We did not assess neuron numbers in specific neocortical regions and, as such, any locally restricted loss may have been undetected. We also analyzed mice at only one time point and it is possible that neocortical neuronal loss may appear at later stages.

###### 

Summary of cell and neuron counts from different studies according to brain region and counting method

  **Method**                              **Genetic background**                           **Brain region**   **Cell or neuron number**   **Age of animals and transgene(s) harbored**                                   **Reference**
  --------------------------------------- ------------------------------------------------ ------------------ --------------------------- ------------------------------------------------------------------------------ ---------------
  Isotropic Fractionator                  TgCRND8 (C3H/He-C57BL/6)                         Whole brain        100.10 ± 7.90 x 10^6^       6 months; K670M/N671L/V717F APP                                                Present study
                                          Dutch (C57BL/6J)                                                                                                                                                                
  Isotropic Fractionator                  Swiss Webster                                    Whole brain        108.90 ± 16.25 x 10^6^      2-5 months                                                                     [@B7]
  Isotropic Fractionator                  TgCRND8 (C3H/He-C57BL/6)                         Cerebellum         43.92 ± 2.78 x 10^6^        6 months; K670M/N671L/V717F APP                                                Present study
                                          Dutch (C57BL/6J)                                                                                                                                                                
  Isotropic Fractionator                  Swiss Webster                                    Cerebellum         49.17 ± 5.32 x 10^6^        2-5 months                                                                     [@B7]
  Isotropic Fractionator/Flow Cytometry   C57Bl/6J                                         Cerebellum         44.03 ± 0.42 x 10^6^        60-100 days                                                                    [@B8]
  Isotropic Fractionator                  TgCRND8 (C3H/He-C57BL/6)                         Hippocampus        31.8% decrease in neurons   6 months; K670M/N671L/V717F APP                                                Present Study
  Isotropic Fractionator                  Dutch (C57BL/6J)                                 Hippocampus        No decrease in neurons      18 month Dutch E693Q APP mice                                                  Present study
  Stereology                              C57BL/6                                          CA1                \~25% decrease in neurons   14-18 month-old TgAPP23 (K670M/N671L) mice                                     [@B9]
  Stereology                              APP/ PS1^M146L^ (CBA - 12.5% × C57Bl6 - 87.5%)   CA1-CA3            \~30% decrease in neurons   17 month APP (751^*SL*^) and presenilin 1 (PS1^M146L^) mice                    [@B10]
                                          Controls (C57BL/6)                                                                                                                                                              
  Stereology                              (C57BL/6 50%-CBA 25%--129SV 25%)                 CA1/2              \~50% decrease in neurons   10 month APP^SL^PS1KI (APP K670N/M671L, and V717I; PS1 M233T/L235P knock-in)   [@B11]
  Stereology                              C57BL/6J                                         CA1                33% decrease in neurons     6 month APP/PS1KI                                                              [@B12]
                                                                                                                                          (APP K670N/M671L, and V717I; PS1 M233T/L235P knock-in)                          

![**TgCRND8 mutant APP transgenic mice exhibit significantly lower neuronal numbers and densities as compared to Dutch mutant APP transgenic mice.** There was a significant difference observed in neuronal numbers in the hippocampus between TgCRND8 mutant APP mice and their control littermates (**H**). Left column represents TgCRND8 mutant APP mice (black) and their littermate controls (grey) and the right column represents the Dutch mutant APP mice (black) and their littermate controls (grey). Note that the scale of the y-axis changes among the graphs. Values represent mean ± SEM. \*p \< 0.05.](1750-1326-7-58-2){#F2}

Aberrant accumulation of brain Aβ over decades has been proposed to result in synaptic and neuronal loss associated with the progression of AD (for review see [@B13]). Evidence indicates that accumulation of soluble oAβ relates to cognitive impairment in AD patients [@B14]and AD mouse models [@B2][@B3][@B15]. However, the possibility that the severity of neurotoxicity and neuronal loss may be related to levels of Aβ solubility or confirmation (oAβ or fAβ) remains unclear. Using high-resolution 3D reconstructions, intraneuronal accumulation of fAβ has been observed by some investigators who proposed that this fAβ leads to the disruption and degeneration of spines and neurites, and ultimately to neuronal death [@B16], even though other investigators have reported that oAβ alone is sufficient for behavioral dysfunction [@B15].

Importantly, other studies have demonstrated reduced neuron densities in various lines of APP mice following onset of plaque pathology. These observations were primarily derived from the hippocampus and are similar in magnitude to the loss we report in TgCRND8 mice, albeit using different counting methods (Table [1](#T1){ref-type="table"}). Using a stereologic approach, Calhoun et al. ([@B9]) found a \~25% loss of CA1 neurons in TgAPP23 mice, while Schmitz et al. ([@B10]) found a \~30% loss of neurons in the CA1-3 regions in an APP/PS1 double mutant mouse, and Breyhan et al. ([@B12]) found a 33% loss of CA1 pyramidal neurons in APP/PS1 knock-in mice. Our results indicate that, in wildtype mice, estimates derived from the isotropic fractionator are generally comparable to stereologic estimates. Most importantly, we observed an apparent neuronal loss in TgCRND8 mice that form oAβ, insoluble fAβ, and amyloid plaques, but not in Dutch mice that produce only oAβ. It is evident that both oAβ and fAβ are toxic and implicated in the neurodegeneration process. However, various Aβ species may impair neuronal function via different mechanisms, and clarification of this point merits further investigation.

Methods
=======

Animals
-------

Eight 6-month-old TgCRND8 APP^K670N/M671L/V717F^ mice and seven wildtype littermates, as well as nine 18-month-old Dutch APP^E639Q^ mice and eight of their littermates were used in this study. These ages were chosen as previous studies demonstrated clear behavioral impairments and amyloid deposition in the TgCRND8 mice and intracellular accumulation in the Dutch mice at these time points [@B3][@B5]. All mice used in the current study were group-housed, given *ad libitum* access to food and water, and housed under a 12-hour light/dark cycle. All animal procedures were conducted in accordance with the National Institute of Health Guidelines for the Care and Use of Experimental Animals and were approved by the Institutional Animal Care and Use Committee of the Icahn School of Medicine at Mount Sinai.

Animals were perfused as previously described [@B17]. Brains were removed from the skull and postfixed in 4% PFA at 4°C. Brains were weighed, cut into half, and further dissected into three regions, cerebellum, hippocampus, and neocortex and weighed. Results were multiplied by 2 to obtain estimates of cell numbers for the entire brain. In addition, brains were immunostained with the anti-amyloid monoclonal antibody 6E10 (Covance) as described in [@B15].

Isotropic fractionator
----------------------

The isotropic fractionator is a fast and reliable technique for determining total cell and neuronal counts and cell densities in the brain. The procedure involves processing of highly anisotropic brain structures into homogeneous isotropic suspensions of cell nuclei that can be easily quantified [@B6]. Because the estimates of cell counts are obtained separately from the determination of brain volume, the two measurements can be used in comparative studies of brain-volume variation (i.e., comparing across species or between different mouse lines [@B6]). Briefly, postfixed samples were mechanically dissociated and homogenized in a solution of 40 mM sodium citrate and 1% Triton X-100 as previously described [@B6]. The homogenates were collected and the homogenizer washed at least twice to collect any residual cells. To visualize nuclei and obtain total cell counts, 1 μl of 4',6-diamidino-2-phenylindole (Sigma) was added to the cell suspension (volumes according to brain region; 10 ml for cerebellum and neocortex, 3 ml for hippocampus. The volume for each brain region was optimized so that at least 500 nuclei could be counted) To determine total neuron counts, 1 ml of each cell suspension was removed, washed with PBS, and centrifuged for 10 minutes at 4000 x g. Cells were then incubated in anti-NeuN antibody (1:200; Millipore) for 2 hours followed by incubation in a secondary anti-mouse IgG-Alexa-Fluor 594 for 1.5 hours (1:200; Millipore). Cells were then counted with a hemocytometer using a 20X/0.45 N.A., Plan-Apochromat objective on a Zeiss Axiophot microscope equipped with a motorized stage. All four quadrants in both the upper and lower grids of the hemocytometer were counted and averaged. Total cell numbers and neuronal numbers were calculated by multiplying the number of cells/ml by final volume. Densities were calculated by dividing the number of cells/ml by the mass of brain region.

Statistics
----------

All statistical analyses were performed using SPSS v19.0. Independent samples *t*-tests were used for comparison of TgCRND8 mutant APP or Dutch mutant APP mice to their respective littermates. Levene\'s test for homogeneity of variance was used for inclusion in parametric tests (*p* \> 0.05). Significance for *t*-tests are reported with a *p* value \< 0.05 using two-tailed tests with an α level of 0.05. Values represent mean ± SEM.
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